How much does generic lorlatinib cost?

Lorlatinib is a third-generation targeted therapy drug mainly used to treat ALKpositive (anaplastic lymphoma kinase) and ROS1positive (C-rosproto-oncogene1) non-small cell lung cancer (NSCLC). It has an anti-cancer effect by inhibiting the growth of cancer cells related to ALK and ROS1 gene mutations. It is especially suitable for patients who are resistant to other ALK inhibitors (such as crizotinib, afatinib, etc.). Lorlatinib has a strong ability to penetrate the blood-brain barrier and can effectively treat brain metastatic tumors, which makes it clinically important for lung cancer patients with brain metastases.

Larlatinib has been launched in China and has been included in medical insurance. Patients can purchase it through medical insurance reimbursement. Although it is covered by medical insurance, because it is an imported drug, its price is relatively high, generally between 10,000 and 2 RMB. The specific price will vary according to different regions, hospitals and medical insurance reimbursement policies. Patients can consult the hospital pharmacy for specific prices and medical insurance reimbursement status. Although medical insurance can alleviate some of the burden, patients still need to bear greater financial pressure, especially those who require long-term medication.

In foreign countries, the price of lorlatinib varies. The main original drug versions are as follows:

1.Hong Kong original drug: The price of the original drug lorlatinib in Hong Kong is relatively high, usually 3 RMB per bottle.

2.Turkish original drugs: The original drugs produced in Turkey are relatively cheap, about7000 yuan, which is cheaper than the Hong Kong version, but still more expensive.

As the market demand for lorlatinib increases, many countries have also begun to produce generic drugs. The main generic drugs come from regions such as Bangladesh and Laos. The prices of these generic drugs are relatively affordable, usually ranging from 1000 yuan to 5000between yuan and renminbi. Generic drugs have the same ingredients as the original drugs, so their therapeutic effects and safety are basically the same. Due to the lower production costs of generic drugs, they have become the choice of many patients with greater financial pressure.

As a highly efficient targeted drug, lorlatinib has significant efficacy in the treatment of non-small cell lung cancer. However, due to its high price, patients need to make a balance between medical insurance reimbursement and financial affordability. Generic drugs offer patients a more economical option.

xa0

Reference materials

1.State Food and Drug Administration drug approval number and instructions - https://www.nmpa.gov.cn/

2.ALKTreatment Guidelines for Positive Non-Small Cell Lung Cancer - https://www.caca.org.cn/